Exploring early combination strategy in Latin American patients with newly diagnosed type 2 diabetes: a sub-analysis of the VERIFY study.
Sérgio VencioJuan P ManosalvaChantal MathieuPieter ProotHernan Yupanqui LoznoPäivi M PaldániusPublished in: Diabetology & metabolic syndrome (2021)
Similar to the global population, long-term clinical benefits were achieved more frequently and without tolerability issues with EC versus standard-of-care MET in this Latin American sub-population. This study is registered with ClinicalTrials.gov, NCT01528254.